INCYHealthcareLarge-Cap

INCYTE CORP Insider Trading Activity

Every SEC Form 4 insider transaction reported for INCYTE CORP (INCY), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are INCY insiders buying or selling?

INCYTE CORP insiders reported 8 open-market buys ($288.3M) and 180 sells ($183.8M) across 188 Form 4 filings — a net buying position of $104.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Aug 20, 2026)

Total Form 4 filings
188
SEC EDGAR
Insider filers
24
Insider buys (8)
$288.3M
Insider sells (180)
$183.8M

Insider sentiment

Net buying

Net insider flow of $104.5M in net buying.

Recent INCY insider transactions

DateInsiderRoleTypeSharesPriceValue
Aug 20, 2026Pablo J CagnoniPresident, Global Head of R&DSale10.8K$125.56$1.4M
Aug 14, 2026Pablo J CagnoniPresident, Global Head of R&DSale10.8K$120.04$1.3M
Aug 7, 2026Pablo J CagnoniPresident, Global Head of R&DSale10.6K$122.69$1.3M
Aug 7, 2026Patrick A MayesEVP & Chief Scientific OfficerSale2.2K$123.99$273.6K
Aug 4, 2026Pablo J CagnoniPresident, Global Head of R&DSale15.9K$119.70$1.9M
Aug 4, 2026Patrick A MayesEVP & Chief Scientific OfficerSale48.0K$119.58$5.7M
Jul 20, 2026Steven H SteinCMO & Head of Late-Stage Dev.Sale1.9K$114.73$215.3K
Jul 20, 2026Mohamed Khairie IssaEVP, Head of U.S. CommercialSale1.1K$115.01$125.7K
Jul 16, 2026Steven H SteinCMO & Head of Late-Stage Dev.Sale28.2K$113.05$3.2M
Jun 8, 2026Thomas TrayPrincipal Accounting OfficerSale2.6K$100.00$263.9K
May 28, 2026Thomas TrayPrincipal Accounting OfficerSale2.1K$97.35$199.7K
May 21, 2026Paul J ClancyDirectorSale15.0K$94.93$1.4M
Apr 21, 2026Pablo J CagnoniPresident, Global Head of R&DSale18.7K$96.50$1.8M
Mar 19, 2026Pablo J CagnoniPresident, R&DSale18.7K$94.24$1.8M
Feb 23, 2026Pablo J CagnoniPresident, R&DSale18.7K$100.91$1.9M
Jan 8, 2026Mohamed Khairie IssaEVP, Head of US OncologySale10.9K$109.07$1.2M
Jan 7, 2026Steven H SteinEVP & Chief Medical OfficerSale15.6K$101.70$1.6M
Dec 23, 2025Thomas TrayPrincipal Accounting OfficerSale3.4K$99.69$336.4K
Dec 18, 2025Michael James MorrisseyEVP, Head of Tech. OperationsSale58.3K$97.29$5.7M
Dec 12, 2025Patrick A MayesEVP & Chief Scientific OfficerSale5.8K$95.55$555.0K
Dec 3, 2025Steven H SteinEVP & Chief Medical OfficerSale22.7K$102.56$2.3M
Nov 25, 2025Thomas TrayPrincipal Accounting OfficerSale769$102.78$79.0K
Nov 19, 2025Sheila A. DentonEVP & General CounselSale278$104.36$29.0K
Nov 12, 2025Herve HoppenotDirectorSale187.5K$105.46$19.8M
Nov 7, 2025Steven H SteinEVP & Chief Medical OfficerSale5.2K$102.20$534.8K

Showing the 25 most recent of 188 Form 4 filings for INCYTE CORP.

Most active INCY insiders

  • Barry P Flannelly22 filings
  • Paula J Swain22 filings
  • Dashyant Dhanak19 filings
  • Steven H Stein17 filings
  • Vijay K Iyengar17 filings

Ask anything about INCY insider activity

Use Trabud's AI agent to query INCYTE CORP's Form 4 history in plain English — "Show me INCY CEO purchases this year" or compare it against any other ticker.

Open the AI agent

INCY insider trading FAQ

Are INCYTE CORP insiders buying or selling?

Across 188 SEC Form 4 filings, INCYTE CORP (INCY) insiders reported 8 open-market purchases totaling $288.3M and 180 sales totaling $183.8M. That is a net buying position of $104.5M.

How many insiders trade INCY stock?

24 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for INCYTE CORP. The most recent filing was accepted on Aug 20, 2026.

Where does Trabud get INCY insider trading data?

All INCY insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content